VIVUS
VIVUS, Inc. is a drug-development company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity, diabetes, sleep apnea and sexual health.
VIVUS
Social Links:
Industry:
Biopharma Biotechnology Health Care
Founded:
1991-01-01
Address:
Mountain View, California, United States
Country:
United States
Website Url:
http://www.vivus.com
Total Employee:
51+
Status:
Active
Contact:
6509345389
Email Addresses:
[email protected]
Total Funding:
53.6 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Apple Mobile Web Clips Icon Google Font API Google Tag Manager Google Maps LetsEncrypt HSTS IPv6
Similar Organizations
Akari Therapeutics
Akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Dare Bioscience
Daré Bioscience is a healthcare company committed to the development and commercialization of innovative products.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
PEURegen
PEURegen Inc. is dedicated to the development/commercialization of a synthetic skin scaffold platform .
QLT Inc
QLT is a biotechnology company dedicated to the development and commercialization of innovative ocular products.
Receptos
Receptos focuses on the discovery, development and commercialization of various therapeutics for immune disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Current Employees Featured
Stock Details
Investors List
Franklin Templeton
Franklin Templeton investment in Post-IPO Equity - VIVUS
EuclidSR Partners
EuclidSR Partners investment in Post-IPO Equity - VIVUS
Caxton Advantage Life Sciences Fund
Caxton Advantage Life Sciences Fund investment in Post-IPO Equity - VIVUS
OrbiMed
OrbiMed investment in Post-IPO Equity - VIVUS
Quogue Capital
Quogue Capital investment in Post-IPO Equity - VIVUS
Deerfield
Deerfield investment in Post-IPO Debt - VIVUS
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Venture Round - VIVUS
Domain Associates
Domain Associates investment in Seed Round - VIVUS
Official Site Inspections
http://www.vivus.com Semrush global rank: 3.98 M Semrush visits lastest month: 2.75 K
- Host name: 52.183.81.53
- IP address: 52.183.81.53
- Location: United States
- Latitude: 47.6092
- Longitude: -122.3314
- Timezone: America/Los_Angeles
More informations about "VIVUS"
VIVUS: Advancing Innovative Clinical Therapies
With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting …See details»
VIVUS: Advancing Innovative Clinical Therapies
With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting …See details»
Corporate executive team - Vivus
We are a focused organization with the expertise and insights to advance innovative new therapies. With demonstrated clinical development and commercialization expertise, VIVUS is …See details»
VIVUS - Crunchbase Company Profile & Funding
VIVUS, Inc. is a drug-development company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity, …See details»
Vivus - Wikipedia
Vivus (OTC Pink: VVUSQ) is a small pharmaceutical company headquartered in Campbell, California, working in obesity, sleep, and sexual health. Vivus developed an erectile dysfunction drug, Avanafil, that has completed Phase 3 clinical trials. The drug has been approved for use by the FDA, and is sold under the trademark name Stendra. Stendra is the first and only oral ED treatment approved to be taken approximately 15 minutes before sexual activity. See details»
Vivus Health
VIVUS Health’s integrated network of healthcare services includes our state-of-the-art, HIPAA-compliant telehealth VHP Platform as well as our secure, online VIVUS Health Store. What …See details»
Vivus - Org Chart, Teams, Culture & Jobs - The Org
VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases. View Vivus' up-to-date org chart, open roles, and culture …See details»
John Amos - CEO at Vivus - The Org
Mr. Amos served as the President of the Oncology Therapeutics Network of Bristol Myers Squibb, a publicly traded biopharmaceutical company, from June 2003 to May 2005. He held executive …See details»
Our history - Vivus
About Us. Our History Executive. Team Compliance. We are a focused organization. We develop high-potential molecules that have compelling safety and efficacy potential, and transform them into proprietary products that …See details»
VIVUS - Overview, News & Similar companies | ZoomInfo.com
VIVUS contact info: Phone number: (888) 998-4887 Website: www.vivus.com What does VIVUS do? We are a focused organization with the expertise and insights to advance innovative new …See details»
VIVUS Company Profile - Office Locations, Competitors, Revenue …
Dec 14, 2020 · VIVUS is a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with …See details»
VIVUS | Our History
Learn about the evolution of VIVUS and the expansion of our business globally. Swipe, click through or select a year to navigate our interactive timeline.See details»
VIVUS Provides Update on Pipeline and Program Milestones
CAMPBELL, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that …See details»
Vivus to be owned by IEH Biopharma ahead of Chapter 11 filing
Jul 10, 2020 · IEH Biopharma LLC is taking 100% ownership of Vivus Inc. under an in-court prepackaged plan of reorganization ahead of the Vivus' Chapter 11 bankruptcy filing. Vivus …See details»
What is VIVUS? Company Culture, Mission, Values | Glassdoor
With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting …See details»
VIVUS | Compliance
VIVUS is committed to conducting its business ethically and in compliance with all applicable laws. Please select from the following: OAG Supply Chains Act Compliance StatementSee details»
Vivus | Background
VIVUS was formed on the back of its innovative Cerebral Palsy program which has medically proven to exhibit profound clinical outcomes. The program relies on a unique method …See details»
Paskola | Vivus Finance
Vivus Finance - lanksčios paskolos iki 15000 EUR itin geromis sąlygomis, su galimybe rinktis grąžinimo terminą net iki 84 mėnesių.See details»
VIVUS | VIVUS Contact Directory - Americas
For general questions about VIVUS or for media inquiries, please contact us using the information provided below. Please note, we cannot respond to questions about general medical …See details»
Herzlich willkommen auf vivus.org
Webhosting für privat, Vereine und Organisationen finden Sie bei.See details»